Moose River Research LLC

Located in Maple Grove, MN, Aspen Research is a cutting-edge laboratory at the forefront of scientific innovation. Nestled within the vibrant community of Maple Grove, this facility serves as a hub for groundbreaking research and experimentation. Surrounded by the natural beauty of the area, Aspen Research provides a serene backdrop for scientific exploration. With state-of-the-art equipment and a team of dedicated researchers, Aspen Research is committed to pushing the boundaries of knowledge and discovery. From conducting intricate experiments to analyzing complex data, this laboratory plays a vital role in advancing various fields of study. As a key player in the scientific community, Aspen Research stands as a beacon of excellence and ingenuity in Maple Grove, MN. Generated using this place's available information

Innovative Research, LLC, based in Minneapolis, MN, specializes in computational fluid dynamics (CFD) modeling software for data centers, electronics cooling, and general flow systems. Their flagship products, TileFlow and MacroFlow, offer advanced and user-friendly tools designed to predict thermal and flow behavior in various engineering applications. The company's MeltFlow software suite provides in-depth analysis for the Vacuum Arc Remelting and Electroslag Remelting processes, enabling manufacturers to optimize production of high-quality alloys. With a global client base that includes data center managers, equipment manufacturers, and specialty metals companies, Innovative Research is committed to delivering efficient and reliable solutions across diverse industries. Generated from the website

ABOUT CVRx Company Overview CVRx is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is well financed and supported by an outstanding board of directors. They have established a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. Hypertension affects over 73 million people in the United States and is estimated to cause 1 in every 8 deaths worldwide1 It is a major risk factor for cardiovascular disease, morbidity and mortality. It is a costly disease and yearly costs to treat hypertension in the United States are estimated to be $69.4 billion1 Twenty-five percent of people with hypertension cannot adequately control their hypertension with medications and lifestyle modifications 2, 3 It is a disease that needs new treatment solutions. Heart failure affects over 5 million people in the United States and is associated with a high risk of dying, with a five-year mortality rate of 74%.4, 5 It has a severe impact on quality of life with symptoms including: general fatigue and weakness; shortness of breath and swelling in the legs and ankles. It is also a costly disease, with an estimated direct and indirect costs of $37.2 billion annually in the United States.6 There are no proven treatments available today that improve the function of the heart in individuals with heart failure caused by heart filling problems, also called diastolic heart failure. Diastolic heart failure accounts for up to 50% of heart failure cases.7